In subsequent years, the plant intensively developed the production of substances by microbiological synthesis and became one of the largest pharmaceutical companies of the Soviet Union. The oleandomycin, tetracycline, nystatin, heliomycin, fusidine, levorin, griseofulvin, riboxin substances and some of other drugs were of high quality and stability.
The quality of manufactured products has always been the main objective of the Company, and in 2002 a new laboratory complex of the Quality Control Department was built and certified by the Ministry of Health of Russia for technical competence.
Since 2005, modernization of the main production facilities has been actively started. For example, in 2006, according to the technical re-equipment plan, a new blister filling site was put into operation.
In 2007, the Company launched production of cephalosporin powders for injections certified for the compliance with the EU GMP requirements.
In 2012, the Advanced Research and Educational Center was created on the basis of the Biosintez Central Laboratory. As part of the implementation of the Federal Target Staff Training Program for Biomedical and Pharmaceutical Industries, the Company created an internship site aimed at improving academic mobility of teachers and students, developing innovative entrepreneurship skills in biomedical and pharmaceutical fields. At dedicated workplaces, students are able to get an understanding of both manufacturing process and procedures for production management, quality control and research and development in real production conditions.
From 2009 to 2013, the Ministry of Industry and Trade of the Russian Federation repeatedly awarded OJSC “Biosintez” as the Best Exporter of the pharmaceutical industry and in different years the Company was awarded as the most dynamically developing exporter of the pharmaceutical industry, the best exporter to the CIS countries.
From 2012 to 2014, the Company, a complete reconstruction and modernization of all production facilities of the Company was performed as part of the large-scale investment project "Modernization of production of medicines at OJSC “Biosintez”.
Biosintez, PJSC is one of the first Russian companies to receive GMP certificate issued by the Ministry of Industry and Trade of the Russian Federation at the beginning of 2015.
Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world with manufacturing facilities in more than 150 countries.
Sun Pharma is famous for its high-quality medicines and trusted by patients and healthcare professionals across the globe.
In May 2019, PJSC “Biosintez” launched a new site for manufacturing solid formulations with a capacity of up to 2 billion tablets per year, as well as a state-of-art logistics complex.
The GMP Certificate was obtained as a result of the audit in January 2019.
In October 2020, PJSC “Biosintez” having making major preparatory efforts in close cooperation with the Industrial Development Fund (IDF) introduced the state drug labeling system at the Company. Currently, the system is installed on all packaging lines and operates in data transfer mode.
Today, PJSC “Biosintez” is a member of San Pharma group of companies and a large high-tech enterprise that meets the national standards of the pharmaceutical industry. Currently, the range of products of the Company includes more than 160 types of medicines and is heavily marketed in the Russian Federation, CIS countries and far abroad.
At the beginning of 2022, PJSC “Biosintez” put a new gas boiler house into operation for the steam and hot water generation. This project allows the company to reduce the cost of thermal carriers and improve their quality, ensure uninterrupted operation of production shops through autonomous and independent steam supply.
